yourself, not that we gave you the data. Set out what data was collected in order to carry out the audit, and how you analysed this (note this is not the results of your analysis, but the methods of how to do the analysis). You should probably also set out here what the target is you are aiming for; if you remember we said in the introduction session that a key thing about audits is that you are assessing performance against a set standard, so what is the standard that you are aiming for? Note that we've not told you a set standard you are aiming for, we are looking for you to set a sensible standard. We've given you some clues in the questions we asked you to find answers to: What is the MEAN number of PPI issues over 12 months? What is the MEAN number of alginate issues in the same period? What is the PERCENTAGE of patients on PPIs who are issued >2 alginate antacids in 12 months? Of these points, can you find any indications about how many of these medications patients should be getting prescribed? Are there limits suggested anywhere? Results - This is largely what you generated during the TBL session in answering those 3 questions we gave you. How to present that is up to you. I wouldn't include the entire dataset you were working with as that would just be a massive table which wouldn't be very informative. It may be worth summarising the data by including a table with factors such as the mean and any other points you think may be relevant. Discussion - the results section is where you state what your results are. The discussion is where you consider what your results mean. We asked you analyse the data about PPI and alginate issues over the last 12 months. Relate that to the target you set, how does this compare to the target? Are there any numbers in your analysis too high, or too low? If so, why might this be? Action plan and recommendations - if you identified any problems through your audit of this data, what recommendations can you make to improve the situation? Use an action plan (e.g. SMART action plan) to set out how you would implement any changes. Make sure you include something on how/why this change would help. Word count - Several people asked if the action plan would be included in the word count. If you include it in the main text, then yes, but keep in mind a SMART action plan can easily be formatted as a table and that figures and tables don't count towards the word count. For references, citations in the text usually do count towards the word count but the reference list at the end doesn't. There is a 10% tolerance on the word count, so with a 1000 word limit you'll only get penalties if you go over 1100 words. References - you probably won't need many references for this, certainly fewer than you used in the report, but you still should cite appropriately. For example, in you introduction when you set out the topic and potential problem, you might refer to some published literature on the topic, or a relevant section of the NICE Guidelines. When considering your action plans, perhaps there might be some published literature to support the actions you're taking, showing that these actions have previously worked elsewhere./n 23 Your audit assignment A recent review by the NHS England team found that many patients are being co-prescribed PPIs in addition to alginate antacids when there is no clinical need. • Preliminary data would suggest that on average, practices within the ICS are within the highest quintile (top 20%) of practices throughout the country for co- prescribing PPIs in addition to alginate antacids. Feb 2022 GAVISCON LIQUE GAVISCON GAVISCON GAVISCON MESLE ACTION Healthcare Professional: AUDIT 89 shutterstock.com. 1457661998 AV AVELA ASSIGNMENT BRIEF: You must prepare a 1000 word audit report using the template provided. This is an individual assignment. Your team will be given a dataset, and you can work together on the analysis of this dataset, but the assignment you submit must be your own individual work. It will be processed through a similarity checker (Turltln). Background The national NHS England team have asked Integrated Care Systems (ICSs) to review their drug budget for the current financial year and your ICS has announced several projects in their "Quality, Innovation, Productivity and Prevention" (QIPP) programme for the current financial year. One of the priority areas identified by NHS England has been around management of reflux. Recent data has found that many patients are being co-prescribed Proton Pump Inhibitors (PPIs) in addition to alginate antacids (e.g. Gaviscon®) when there is no clinical need. Preliminary data would suggest that on average, practices within your ICS are within the highest quintile (top 20%) of practices in England for this practice which may be wasteful, or suggest that patients with reflux are inadequately managed. Task 1: Analyse the data All practices within the local ICS have reported on patients who are prescribed PPI and/or alginate antacids within the last 12 months. You have been provided a data set for one of the practices. Complete the following audit activity in class, working with your team to process the data. We anticipate that you will work on this during the TBL workshop (on either 24th or 25th January, depending on your team). You can do the analysis any time, but we recommend making use of these sessions for the analysis as staff will be present to help with any issues. 1. Calculate the mean number of PPI issues in 12 months. 2. Calculate the mean number of alginate antacid issues in 12 months. All practices within the local ICS have reported on patients who are prescribed PPI and/or alginate antacids within the last 12 months. You have been provided a data set for one of the practices. Complete the following audit activity in class, working with your team to process the data. We anticipate that you will work on this during the TBL workshop (on either 24th or 25th January, depending on your team). You can do the analysis any time, but we recommend making use of these sessions for the analysis as staff will be present to help with any issues. 1. Calculate the mean number of PPI issues in 12 months. 2. Calculate the mean number of alginate antacid issues in 12 months. 3. Determine the percentage of patients who order more than TWO alginate prescriptions in 12 months. Task 2: Generate an audit report Using this template, you should each produce a 1000-word report on your findings from this QIPP project, to inform staff within the practice about; 1. The current level of performance and 2. Based on the current performance level, make recommendations for future steps. Your individual report should be submitted to Canvas on the Audit Report template. Deadline 14th Feb, 11am. Some further guidance on the different sections of the report were shared in this announcement. DATA SETS (different for each TBL Team) are available below. Select the appropriate file based on your team number. Within the file, you will find a specific tab for your team. That tab contains the data you should work with. Audit Stage 2 Data Teams 1-10.xlsx Audit Stage 2 Data Teams 11-20.xlsx Audit Stage 2 Data Teams 21-30.xlsx copy to edit. 24 UNIVERSITY of BRADFORD Your audit assignment • In the workshop... Provided a data set from your practice - Working within your TBL team: 1. Calculate the MEAN number of PPI issues over 12 months 2. Calculate the MEAN number of alginate issues in the same period • Determine the PERCENTAGE of patients on PPIs who are issued >2 alginate antacids in 12 months. Feb 2022 Healthcare Professional: AUDIT Save a copy